|Title:||5-Lipoxygenase pathway gene polymorphisms: Lack of association with asthma in a Spanish population||Authors:||Torres-Galván, M. J.
Cumplido, J. A.
|UNESCO Clasification:||32 Ciencias médicas
|Issue Date:||2009||Journal:||Journal of Investigational Allergology and Clinical Immunology||Abstract:||Background: Cysteinyl-leukotrienes are mediators of inflammatory responses in bronchial asthma. We studied the genes encoding the enzymes involved in their synthesis to identify risk factors for asthma. The promoter polymorphisms LTC4S -444 A/C, ALOX5 -176/-147, and ALOX5AP -169/-146 have been reported to be associated with bronchial asthma. Methods: We analyzed the effects of LTC4S -444 A/C, ALOX5 -176/-147, and ALOX5AP -169/-146 on asthma susceptibility by means of a case-control study with 193 ethnically matched, unrelated individuals. Participants were classified as severe asthmatics, nonsevere asthmatics, and nonasthmatics, using a combination of 2 techniques: polymerase chain reaction-restricted fragment length polymorphism and multiplex capillary electrophoresis. Results: No association was found between these polymorphisms and asthma, neither individually nor in combination. Conclusion: Although the studied polymorphisms have been previously reported to constitute risk factors for the disease, we found no association between LTC4S -444 A/C, ALOX5 -176/-147, and ALOX5AP -169/-146 polymorphisms and bronchial asthma.||URI:||http://hdl.handle.net/10553/50223||ISSN:||1018-9068||Source:||Journal of Investigational Allergology and Clinical Immunology[ISSN 1018-9068],v. 19(6), p. 453-458|
|Appears in Collections:||Artículos|
checked on Jun 4, 2023
checked on Sep 24, 2022
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.